Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The market for powder absorbable hemostats has been experiencing notable growth, driven by advancements in surgical methods and increasing awareness about effective blood loss control. As healthcare procedures continue to evolve, this sector is set to expand further, influenced by demographic shifts and technological innovations. Let’s explore the current market size, the key factors pushing demand, important segments, and emerging trends shaping the future of this industry.

Steady Increase and Projected Growth in the Powder Absorbable Hemostat Market

The powder absorbable hemostat market has shown solid expansion in recent years. It is projected to increase from $2.48 billion in 2025 to $2.66 billion in 2026, registering a compound annual growth rate (CAGR) of 7.3%. This upward trend stems from the rising number of surgical interventions, growing awareness around managing blood loss effectively, the availability of materials like collagen and gelatin, a demand for rapid hemostasis, and the adoption of modern surgical technologies. Looking ahead, the market is expected to reach $3.5 billion by 2030, growing at a CAGR of 7.1%. Factors contributing to this future growth include breakthroughs in powder hemostat formulations, the rise in minimally invasive surgeries, expansion of ambulatory surgical centers, an aging population, and increased healthcare spending. Forecasted market trends also point to the growing popularity of minimally invasive procedures, fast-acting hemostatic solutions, biocompatible and bioresorbable materials, customizable powder formulations, and the rise of outpatient surgical treatments.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25881&type=smp

Increasing Surgical Procedures as a Key Growth Driver in the Powder Absorbable Hemostat Market

The rising number of surgeries worldwide is a major factor boosting demand for powder absorbable hemostats. Surgical operations, which involve direct intervention either manually or with instruments to treat injuries or manage diseases, have been increasing due to the growing prevalence of chronic conditions that often require surgical care. This surge in surgeries heightens the need for effective bleeding control solutions, making powder absorbable hemostats valuable for their ability to provide quick and precise hemostasis, particularly in delicate or minimally invasive procedures, thereby improving patient outcomes. For example, in March 2023, the British Association of Aesthetic Plastic Surgeons reported that 31,057 cosmetic surgeries were performed in the UK in 2022, representing a 102% increase from the previous year. This substantial growth in surgery numbers supports the expanding market for powder absorbable hemostats.

Technological Advances Driving Demand in the Powder Absorbable Hemostat Market

Innovation plays a crucial role in expanding the powder absorbable hemostat market. Companies are focusing on developing advanced products such as plant-based polysaccharide absorbable hemostat powders, which improve clotting efficiency and enhance safety during surgical procedures. Made from refined natural starch, these powders quickly absorb blood to initiate clotting and are fully bioresorbable, eliminating the need for removal after use. For instance, in July 2023, Baxter International Inc., a U.S.-based healthcare company, introduced PERCLOT—a starch-derived passive absorbable hemostatic powder designed for patients with intact coagulation to manage mild surgical bleeding. PERCLOT’s granules rapidly absorb water, forming a gelled adhesive barrier that promotes clot formation by attracting platelets, red blood cells, and coagulation proteins. This product complements Baxter’s existing hemostat portfolio by helping reduce blood transfusions, complications, and overall healthcare costs.

Access The Complete Powder Absorbable Hemostat Market Report:

https://www.thebusinessresearchcompany.com/report/powder-absorbable-hemostat-global-market-report

Detailed Segmentation of the Powder Absorbable Hemostat Market

The powder absorbable hemostat market is categorized into multiple segments for better market analysis:

– Product Type: Collagen-Based Hemostats, Gelatin-Based Hemostats, Cellulose-Based Hemostats, Combination Hemostats

– Formulation: Powder Formulations, Ready-To-Use Formulations, Pre-Mixed Formulations, Custom Formulations

– Distribution Channel: Direct Sales, Distributors

– Application: Surgical Procedures, Trauma Care, Orthopedic Surgeries, Cardiovascular Surgeries

– End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Outpatient Surgery Facilities, Other End-Users

Further subcategories include:

– Collagen-Based Hemostats: Bovine Collagen Hemostats, Porcine Collagen Hemostats, Synthetic Collagen Hemostats

– Gelatin-Based Hemostats: Porcine Gelatin Hemostats, Bovine Gelatin Hemostats, Recombinant Gelatin Hemostats

– Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Hemostats, Oxidized Cellulose Hemostats, Carboxymethyl Cellulose Hemostats

– Combination Hemostats: Collagen + Gelatin, Collagen + Cellulose, Gelatin + Cellulose, and Multi-component (Collagen + Gelatin + Cellulose) Hemostats

Competitive Landscape of the Powder Absorbable Hemostat Market

The powder absorbable hemostat market features several key players leading product innovation and market penetration. These include Johnson & Johnson, Baxter International, Integra LifeSciences Corporation, Hangzhou Singclean Medical Products Co. Ltd., Gelita Medical GmbH, Algan Grup Sağlık Hizmetleri, Ferrosan Medical Devices, Hemostasis LLC, CuraMedical B.V., BioCer Entwicklungs GmbH, Medcura Inc., Starch Medical Inc., Aegis Lifesciences, Hemostat Medical GmbH, B. Braun Melsungen AG, Pfizer Hospital Products, Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Anika Therapeutics Inc., Teleflex Medical, Ethicon Biosurgery, and Z Medica LLC. Their competitive efforts drive innovation and expand product offerings in this evolving field.

Regional Distribution and Growth Highlights in the Powder Absorbable Hemostat Market

In 2025, North America held the largest share of the powder absorbable hemostat market, reflecting the region’s advanced healthcare infrastructure and high adoption of surgical innovations. Meanwhile, the Asia-Pacific region is expected to emerge as the fastest-growing market during the forecast period, driven by increasing healthcare investments, growing surgical volumes, and expanding medical facilities. The market study includes key geographic areas such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model